Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion

被引:52
作者
Forconi, Francesco [1 ]
Rinaldi, Andrea [2 ]
Kwee, Ivo [2 ,3 ]
Sozzi, Elisa [1 ]
Raspadori, Donatella [1 ]
Rancoita, Paola M. V. [2 ,3 ]
Scandurra, Marta [2 ]
Rossi, Davide [4 ,5 ]
Deambrogi, Clara [4 ,5 ]
Capello, Daniela [4 ,5 ]
Zucca, Emanuele [6 ]
Marconi, Daniela [5 ,7 ]
Bomben, Riccardo [7 ]
Gattei, Valter
Lauria, Francesco [1 ]
Gaidano, Gianluca [4 ,5 ]
Bertoni, Francesco [2 ]
机构
[1] Univ Siena, Dipartimento Med Clin & Sci Immunol, Sez Ematol & Trapianti, I-53100 Siena, Italy
[2] Oncol Inst So Switzerland, Expt Oncol Lab, Bellinzona, Switzerland
[3] Ist Dalle Molle Studi Intelligenza Artificiale, Manno, Switzerland
[4] Univ Piemonte Orientale Amedeo Avogadro, Dipartimento Genet Clin & Sperimentale, Div Ematol, Novara, Italy
[5] Univ Piemonte Orientale Amedeo Avogadro, BRMA, Novara, Italy
[6] Oncol Inst So Switzerland, Lymphoma Unit, Bellinzona, Switzerland
[7] IRCCS, Ctr Riferimento Oncol, Clin & Expt Oncohematol Unit, Aviano, PN, Italy
基金
瑞士国家科学基金会;
关键词
chronic lymphocytic leukaemia; 17p13; deletion; TP53; genome-wide DNA profile; 250K Affymetrix; single nucleotide polymporphysms;
D O I
10.1111/j.1365-2141.2008.07373.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Deletion of 17p (TP53) identifies a rare subset of chronic lymphocytic leukaemia (17p- CLL) with aggressive behaviour. Genome-wide DNA-profiling was performed to investigate 18 patients with 17p- CLL. All cases had multiple copy-number (CN) changes. Among the several recurrent CN changes identified, 8q24.13-q24.1-gain (MYC), 8p-loss (TNFRSF10A/B, also known as TRAIL1/2) and 2p16.1-p14-gain (REL/BCL11A) appeared frequently represented. 8p-loss and 2p16.1-p14-gain also appeared clinically relevant and predicted significant shorter time from diagnosis to treatment (8p-loss) and overall survival (8p-loss and 2p16.1-p14-gain, P < 0.05). These observations document a highly unstable genome in 17p- CLL and suggest that additional genes outside the TP53 locus may be important for tumour behaviour.
引用
收藏
页码:532 / 536
页数:5
相关论文
共 15 条
[11]   Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia [J].
Saddler, Chris ;
Ouillette, Peter ;
Kujawski, Lisa ;
Shangary, Sanjeev ;
Talpaz, Moshe ;
Kaminski, Mark ;
Erba, Harry ;
Shedden, Kerby ;
Wang, Shaomeng ;
Malek, Sami N. .
BLOOD, 2008, 111 (03) :1584-1593
[12]   Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature [J].
Salaverria, Itziar ;
Zettl, Andreas ;
Bea, Silvia ;
Moreno, Victor ;
Valls, Joan ;
Hartmann, Elena ;
Ott, German ;
Wright, George ;
Lopez-Guillermo, Armando ;
Chan, Wing C. ;
Weisenburger, Dennis D. ;
Gascoyne, Randy D. ;
Grogan, Thomas M. ;
Delabie, Jan ;
Jaffe, Elaine S. ;
Montserrat, Emili ;
Muller-Hermelink, Hans-Konrad ;
Staudt, Louis M. ;
Rosenwald, Andreas ;
Campo, Elias .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (10) :1216-1222
[13]   Automated array-based genomic profiling in chronic lymphocytic leukemia:: Development of a clinical tool and discovery of recurrent genomic alterations [J].
Schwaenen, C ;
Nessling, M ;
Wessendorf, S ;
Salvi, T ;
Wrobel, G ;
Radlwimmer, B ;
Kestler, HA ;
Haslinger, C ;
Stilgenbauer, S ;
Döhner, H ;
Bentz, M ;
Lichter, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (04) :1039-1044
[14]   Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL) [J].
Secchiero, Paola ;
Barbarotto, Elisa ;
Tiribelli, Mario ;
Zerbinati, Carlotta ;
di Iasio, Maria Grazia ;
Gonelli, Arianna ;
Cavazzini, Francesco ;
Campioni, Diana ;
Fanin, Renato ;
Cuneo, Antonio ;
Zauli, Giorgio .
BLOOD, 2006, 107 (10) :4122-4129
[15]  
VEELKEN H, 2007, LEUKAEMIA LYMPHOM S1, V48, pS3